)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Genomtec
Genomtec (GMT) investor relations material
Genomtec Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 earnings summary30 Sep, 2026
Executive summary
Group continued R&D activities in biotechnology and medical devices, focusing on the Genomtec ID diagnostic platform, which is in the industrialization phase with an external partner.
No seasonality or cyclicality in operations; business is funded by equity, grants, and recent share issuance.
Group structure unchanged; 100% ownership in two subsidiaries focused on scientific research.
Financial highlights
Consolidated revenue from sales: 27k PLN for H1 2026, unchanged year-over-year.
Net loss for H1 2026: (4,267)k PLN, improved from (6,555)k PLN in H1 2025.
Cash and equivalents at period end: 14,244k PLN, up from 4,722k PLN at 2025 year-end.
Equity increased to 15,671k PLN from 9,214k PLN at 2025 year-end, mainly due to new share issuance.
Outlook and guidance
Management expects continued negative results and cash outflows until commercialization of developed technologies.
Additional capital may be raised through further share issues to finance commercialization.
Group aims to reach break-even after successful commercialization.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Genomtec
- Net loss narrowed and revenue rose, but continued funding and market risks persist.GMT
Q1 2026 - Patent expansion, cost cuts, and narrowed loss set the stage for commercialization in 2026.GMTQ4 2025
- Net loss widened to PLN -11.2m as R&D continued, with equity raises ensuring 12+ months liquidity.GMTQ4 2024
- Net loss persists as R&D spending rises; commercialization and funding remain critical.GMTQ3 2025
- Rapid genetic diagnostics, strong IP, and robust funding drive growth and M&A momentum.GMTInvestor Presentation
- Net loss deepened to PLN 6.6M as R&D spending rose; commercialization still ahead.GMTQ2 2025
- Genomtec ID and OncoSNAAT are positioned for separate sales as projects advance.GMTInvestor Update
- Losses persist as Genomtec advances R&D, secures funding, and pursues M&A for commercialisation.GMTQ3 2024
- Net loss widened to PLN 6.0 million in H1 2024 as Genomtec advanced R&D and raised new capital.GMTQ2 2024
Next Genomtec earnings date
Q3 202630 Nov, 2026
Genomtec
Next Genomtec earnings date
Q3 202630 Nov, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage